HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Facing Big-League Challenges With P&G's 'Orphan' Brands

This article was originally published in The Rose Sheet

Executive Summary

Investor reactions have been mixed, and Coty's stock down, following the firm's transformative $12.5 deal for 43 P&G beauty brands. Deutsche Bank's Bill Schmitz is confident that longer-term opportunities outweigh immediate risks, but getting up to speed and reinvesting in Wella and Clairol and "cleaning up" distribution of P&G's prestige fragrances will be critical to the firm's success, the analyst says.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel